Body mass and stage of breast cancer at diagnosis

被引:127
作者
Cui, YD
Whiteman, MK
Flaws, JA
Langenberg, P
Tkaczuk, KH
Bush, TL
机构
[1] Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA
[2] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
关键词
breast cancer; stage; body mass; obesity;
D O I
10.1002/ijc.10209
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Obesity is a well-known risk factor for postmenopausal breast cancer. In contrast, the relationship between obesity and stage of breast cancer at diagnosis is less clear. We hypothesized that increased breast size in obese women may delay discovery of breast tumors. Thus, the purpose of our study was to examine whether there is an association between body mass and stage of breast cancer at diagnosis using hospital medical records. Newly diagnosed breast cancer cases (n = 966) in the Baltimore metropolitan area from 1991 to 1997 were included in our study. Patient information including age, ethnicity, weight, height and pathology data were obtained from hospital medical records. High body mass was significantly associated with late stage of breast cancer at diagnosis. Women who were obese (body mass index [BMI] greater than or equal to 27.3) were more likely to be at an advanced stage at diagnosis compared with women with a BMI of < 27.3 (multivariate-adjusted odds ratio [OR] 1.57, 95% confidence interval [CI] 1.15-2.14). The association between body mass and stage at diagnosis was stronger among women younger than 50 years (OR 2.34, 95% Cl 1.34-4.08) compared with women 50 years or older (OR 1.30, 95% Cl 0.89-1.91). Our study suggests that higher body mass is associated with advanced stage of breast cancer at diagnosis. This finding may be of considerable concern, given the increasing prevalence of obesity in women in the United States and the poor prognosis associated with late-stage tumors. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:279 / 283
页数:5
相关论文
共 65 条
[1]  
[Anonymous], 1997, ROSENS BREAST PATHOL
[2]  
BallardBarbash R, 1996, AM J CLIN NUTR, V63, P437
[3]  
BALLARDBARBASH R, 1994, CANCER-AM CANCER SOC, V74, P1090, DOI 10.1002/1097-0142(19940801)74:3+<1090::AID-CNCR2820741518>3.0.CO
[4]  
2-X
[5]   OBESITY AS AN ADVERSE PROGNOSTIC FACTOR FOR PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER [J].
BASTARRACHEA, J ;
HORTOBAGYI, GN ;
SMITH, TL ;
KAU, SWC ;
BUZDAR, AU .
ANNALS OF INTERNAL MEDICINE, 1994, 120 (01) :18-25
[6]  
BEAHRS OH, 1992, MANUAL STAGING CANC, P149
[7]   ENDOGENOUS HORMONES AND BREAST-CANCER RISK [J].
BERNSTEIN, L ;
ROSS, RK .
EPIDEMIOLOGIC REVIEWS, 1993, 15 (01) :48-65
[8]  
BOYD NF, 1981, JNCI-J NATL CANCER I, V67, P785
[9]   Stage of breast and cervical cancer diagnosis in disadvantaged neighborhoods: A prevention policy perspective [J].
Breen, N ;
Figueroa, JB .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 1996, 12 (05) :319-326
[10]   A LINK BETWEEN BREAST-CANCER AND LOCAL ESTROGEN BIOSYNTHESIS SUGGESTED BY QUANTIFICATION OF BREAST ADIPOSE-TISSUE AROMATASE CYTOCHROME-P450 TRANSCRIPTS USING COMPETITIVE POLYMERASE CHAIN-REACTION AFTER REVERSE TRANSCRIPTION [J].
BULUN, SE ;
PRICE, TM ;
AITKEN, J ;
MAHENDROO, MS ;
SIMPSON, ER .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (06) :1622-1628